# Octapharma AB, Stockholm, Sweden – FDA Inspections

Source: https://www.keypedia.com/companies/octapharma-ab/5a456872-4ca6-4418-b006-6e7e219ec262

> Inspection records and compliance data for Octapharma AB in Stockholm. 7 FDA inspections on record (1 OAI), 3 Form 483s, last inspected September 19, 2023.

---

## Details

- Name: Octapharma AB
- FEI Number: 3005559915
- Address Line 1: Lars Forssells Gata 23
- City: Stockholm
- Country Name: Sweden
- Address: Lars Forssells Gata 23, Stockholm, Sweden
- Country: Sweden

## Related Documents

- [483 - Octapharma AB - 2023-09-19](https://www.keypedia.com/records/483/octapharma-ab/39c0cc19-3c92-4f74-935f-51aa7ab303f4) — source: FDA, date: September 19, 2023
- [FDA Inspection 1218250 - Octapharma AB - 2023-09-19](https://www.keypedia.com/records/fda_inspections/octapharma-ab/3645f477-d675-40fc-90b8-3704a595408d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 19, 2023
- [FDA Inspection 1070173 - Octapharma AB - 2018-09-28](https://www.keypedia.com/records/fda_inspections/octapharma-ab/d1bd9bce-fbba-4979-be9f-74a49e7eed87) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 28, 2018
- [FDA Inspection 994537 - Octapharma AB - 2016-10-03](https://www.keypedia.com/records/fda_inspections/octapharma-ab/6b3e378f-099f-4e8b-a570-ba2acbf16cb8) — source: FDA, date: October 3, 2016
- FDA Inspection 894095 - Octapharma AB - 2014-04-28 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 28, 2014
- FDA Inspection 783783 - Octapharma AB - 2012-01-19 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 19, 2012
- [FDA Inspection 710676 - Octapharma AB - 2011-01-20](https://www.keypedia.com/records/fda_inspections/octapharma-ab/e46fa3b2-794a-456e-97d5-2b973b8e1194) — classification: Official Action Indicated (OAI), source: FDA, date: January 20, 2011
- FDA Inspection 580664 - Octapharma AB - 2009-01-29 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 29, 2009

## Related Companies

- [GlaxoSmithKline Vaccines Srl](https://www.keypedia.com/companies/glaxosmithkline-vaccines-srl/3b442668-2065-481f-bc35-a803bb376acc)
- [AstraZeneca Pharmaceuticals LP](https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/f969afa9-62d8-4cde-8873-48180823df9b)
- [LifeSouth Community Blood Centers, Inc](https://www.keypedia.com/companies/lifesouth-community-blood-centers-inc/94ebe4e9-b648-4d51-a063-4ad00b617893)
- [Lonza Netherlands B.V.](https://www.keypedia.com/companies/lonza-netherlands-bv/f39deee8-be7f-41a8-b12e-d2cf810de4c1)
- [Duke Medical Center-Carolinas Cord Blood Bank and Stem Cell Laboratory](https://www.keypedia.com/companies/duke-medical-center-carolinas-cord-blood-bank-and-stem-cell-laboratory/c0d3517e-a147-4272-aa62-323feeca0e0b)
- [Corixa Corporation](https://www.keypedia.com/companies/corixa-corporation/540054c0-cf35-42d2-9056-a9ae897ff412)
- [Kedrion S.p.A.](https://www.keypedia.com/companies/kedrion-spa/89fc7c0d-2ee3-4276-a2ee-e1ba98605ef9)
- [SmartPractice Denmark ApS](https://www.keypedia.com/companies/smartpractice-denmark-aps/e2173ee1-5bc6-4adb-af29-e5c541994c7e)
- [Kamada - Production Plant](https://www.keypedia.com/companies/kamada-production-plant/d3a7a962-b08c-4278-8951-5cad5bcfed41)
- [Takeda Pharmaceutical Company Limited](https://www.keypedia.com/companies/takeda-pharmaceutical-company-limited/4611dabc-52f7-4b4a-96bf-4196e34a7c2b)

## Related Officers

- [Olga Simakova](https://www.keypedia.com/people/olga-simakova/2ee5985e-425e-4732-8869-2be861f5d792)
- [Ze Zeuj](https://www.keypedia.com/people/ze-zeuj/b4ca7158-e9ef-49da-aae5-d78b91e36b0f)
